Sun Pharma Q1FY27 Results: Sales Rise 10.1% to Rs1,518 Mn
Sun Pharma’s Q1FY27 results show consolidated sales up 10.1% to Rs. 151,836 million, net profit at Rs. 28,948 million, and 16% growth in India Formulations, as the Organon acquisition clears a key shareholder milestone ahead of an early-2027 close.
